Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




HYVET: BP Lowering Reduces Fatal Stroke, All-Cause Mortality in the Elderly
Link ID 4481
Title HYVET: BP Lowering Reduces Fatal Stroke, All-Cause Mortality in the Elderly
Url http://www.medscape.com/viewarticle/572335?src=rss
Description Results of a randomized trial show that antihypertensive treatment with a sustained-release formulation of a diuretic reduces fatal stroke, all-cause mortality, and heart failure in elderly patients. Medscape Medical News
Category Articles > Cardiology
Keywords
Date Apr 2, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. ACC 2008: The Future of Managing Dyslipidemia
  ACC.08: Statins may be wonder drugs, but they still leave a significant percentage of patients at risk -- so the latest clinical trial and research results will be good news for treating dyslipidemia. Medscape Cardiology
Category:   Articles > Cardiology


2. Lightheadedness in an Elderly Man
  An 80-year-old man is referred for a preoperative cardiac risk assessment. The patient has experienced periodic lightheadedness and has a history of COPD. An ECG is obtained while the patient experiences an episode of lightheadedness. What rhythm does the first portion of the ECG demonstrate? eMedicine Case Presentations
Category:   Articles > Cardiology


3. High-Dose Candesartan Significantly Reduces Proteinuria
  In the Canadian SMART study, no safety concerns were noted about using large doses of candesartan cilexetil to treat proteinuria. Medscape Medical News
Category:   Articles > Cardiology


4. The Genetics of Statin-Induced Myopathy
  Dr. Eric Topol discusses the newly reported genetic basis for statin-induced myopathy in this videoblog.
Medscape Pathology
Category:   Articles > Cardiology


5. IV Antihypertensive Clevidipine Approved in the US
  The Medicines Company has announced that the US FDA has approved its intravenous antihypertensive clevidipine, which is the first new IV drug for high blood pressure in 10 years. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS